April 2 (Reuters) – Immunovant said on Thursday that its therapy to treat a type of eye disease failed to meet the main goals in a late-stage study.
(Reporting by Sneha S K; Editing by Nivedita Bhattacharjee)
Immunovant’s treatment for eye disease fails late-stage trial
Apr 2, 2026 | 4:05 AM
